Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiwei Chu

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Vaccine|August 19, 2004
Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protectionWei Xu, Yan Shen, Zhenggang Jiang, et al.
Cancer Biology & Therapy|November 26, 2008
Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapyLin Xu, Wei Xu, Zhenggang Jiang, et al.
Immunology Letters|October 30, 2007
Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin betaNing Yu, Wei Xu, Zhenggang Jiang, et al.
Immunology Letters|May 5, 2005
Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing miceShun Lv, Jinping Zhang, Jin Wu, et al.
Cancer Immunology, Immunotherapy : CII|August 14, 2010
Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapyPing Wang, Xiuli Yang, Wei Xu, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2007
In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regressionYiwei Chu, Xiuli Yang, Wei Xu, et al.
DNA and Cell Biology|November 30, 2006
Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosusYongquan Wang, Bin Qiao, Ying Wang, et al.
Infection and Immunity|June 24, 2005
Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesionHuanbin Xu, Wei Xu, Yiwei Chu, et al.
Cellular & Molecular Immunology|May 17, 2011
Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAMYuchan Cai, Shudao Xiong, Yijie Zheng, et al.
Bioorganic & Medicinal Chemistry|May 19, 2019
Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam<sub>3</sub>CSK<sub>4</sub>Xinming Du, Jiawen Qian, Yujie Wang, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Vaccine|August 19, 2004
Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protectionWei Xu, Yan Shen, Zhenggang Jiang, et al.
Cancer Biology & Therapy|November 26, 2008
Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapyLin Xu, Wei Xu, Zhenggang Jiang, et al.
Immunology Letters|October 30, 2007
Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin betaNing Yu, Wei Xu, Zhenggang Jiang, et al.
Immunology Letters|May 5, 2005
Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing miceShun Lv, Jinping Zhang, Jin Wu, et al.
Cancer Immunology, Immunotherapy : CII|August 14, 2010
Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapyPing Wang, Xiuli Yang, Wei Xu, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2007
In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regressionYiwei Chu, Xiuli Yang, Wei Xu, et al.
DNA and Cell Biology|November 30, 2006
Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosusYongquan Wang, Bin Qiao, Ying Wang, et al.
Infection and Immunity|June 24, 2005
Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesionHuanbin Xu, Wei Xu, Yiwei Chu, et al.
Cellular & Molecular Immunology|May 17, 2011
Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAMYuchan Cai, Shudao Xiong, Yijie Zheng, et al.
Bioorganic & Medicinal Chemistry|May 19, 2019
Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam<sub>3</sub>CSK<sub>4</sub>Xinming Du, Jiawen Qian, Yujie Wang, et al.
Pageof 17